Leukemia Treatment
in Israel

Sheba Medical Center offers a variety of advanced treatments for leukemia, the tenth most common cancer, which also accounts for around 30% of all pediatric cancer cases.

At Sheba, we use the latest diagnostic technologies and innovative therapies. Our medical specialists provide the highest level of expertise and devotion to every patient. Read on to find out why Sheba is an ideal choice for those seeking treatment for leukemia abroad.

What Treatments do we offer
at Sheba Medical Center?

Targeted therapy

Drugs or other substances that identify and attack cancer cells without damaging healthy cells. Read More

CAR T-cell therapy

A cutting-edge immunotherapy that involves reprogramming your body’s immune T-cells to fight cancer. Read More

Bone marrow transplant

Transplantation of healthy leukemia-free cells to replace unhealthy bone marrow. Read More


Medicine to eradicate cancer cells. Read More

Radiation therapy

The application of high radiation doses to eliminate cancer cells. Read More


The surgical removal of cancerous tissue masses.

Why Choose Sheba

Premier experts Israeli physicians are exceptionally well-trained and often spend even more time on their medical education than American doctors. Sheba’s staff includes many internationally renowned oncologists.

360-degree care approach for medical tourists Sheba’s 360-degree care approach means that our professionals will be there to support you every step of the way, starting with arranging medical record reviews, to facilitating visas, travel arrangements, accommodations, and language interpretation as needed.

Car T-Cell expertise specialists Sheba’s extensive experience with CAR T-cell therapy speaks louder than words. Under Prof. Arnon Nagler, President of the Hemato-Oncology Division and a world-renowned specialist in the field, we have provided more than 220 patients with CAR T-cell therapy, including 60 children.

Cutting-edge diagnostic tools Sheba’s advanced diagnostic technology enables physicians to customize more precise treatment.

Advanced care Sheba is at the forefront of medical research and offers novel treatments unavailable in other parts of the world while adhering to the highest standards of safety.

Affordable and transparent fees As a government institution, we have no hidden costs, and our fees are transparent. Our prices are affordable even though we offer advanced treatments that are available only in select medical institutions around the world.

Car T-Cell therapy:
a novel Treatment for Leukemia at Sheba Medical Center

Sheba Medical Center is a world leader in the implementation of CAR T-cell therapy for leukemia patients. CAR T-cell therapy is an innovative procedure that makes use of your own immune system to seek and destroy cancerous cells. After some blood is taken from the patient, the T-cells, a type of immune cell, are separated from the rest of the blood in a special laboratory. The T-cells are then genetically engineered to produce chimeric antigen receptors (CARs). The engineered T-cells are then given time to multiply in the laboratory and are later injected back into the patient. The CARs allow the T-cells to recognize, target, and destroy cancer cells.

Unfortunately, as a novel advanced treatment, CAR T-cell therapy is only available in a handful of medical institutions worldwide and tends to be very expensive. At Sheba Medical Center, CAR T-cells are engineered in-house in a specialized laboratory, and as a result, the entire process, from lymphocyte collection to patient delivery, only takes about 10 days. In contrast, many other hospitals use commercial CARs, which must be engineered abroad and shipped back, taking months to become available. This delay allows the patient’s disease to progress further, which can also reduce the effectiveness of the body’s response to the CARs. Furthermore, the shipping process compromises cell quality, as some cells die during the necessary freezing and thawing.

Dima’s Battle
with Leukemia

When doctors told Julia that her 11-month-old son Dima is in a very serious condition and that she should prepare for the worst, she felt like “the ground had fallen out from beneath us.” According to Julia: “We were told that Dima had a 50% chance of recovery, and I simply could not accept that. It was then that I met a family online whose daughter was successfully treated at Sheba Medical Center.”

Meet Sheba’s leading Oncological Clinicians

Arnon Nagler

Prof. Arnon Nagler, MD, M.Sc.

Prof. Arnon Nagler is the Director of both the Division of Hematology and the Bone Marrow Transplantation and Cord Blood Bank at the Sheba Medical Center, while also serving as a professor of medicine at The Tel Aviv University. With over 25 years of experience in the field, Prof. Nagler is a world-renowned hematological expert who pioneered many of the treatments we use today.

amos toren

Prof. Amos Toren, MD, Ph.D., MHA

Prof. Amos Toren is the Director of the Pediatric Hemato-Oncology and BMT Department at Sheba and served 2 terms as the Head of the Hematology Division at the Tel-Aviv University’s school of medicine. In addition, Prof. Toren has a Ph.D. in Genetics, and is qualified as a Master of Health Administration (MHA).


At Sheba, we appreciate that there are other crucial aspects to patient recovery other than the clinical one. Accordingly, our staff pays close attention to all of your needs, while our specialists offer general advice, pain management, dietary guidance, and complementary medical services all under one roof. 

Sheba –

Sheba Medical Center sets the standard for excellence in patient-focused care, and was accordingly included, for the third year in a row, in Newsweek’s prestigious list of Top Ten Best Hospitals Worldwide. This endorsement recognizes Sheba as a leading force in medical science and biotechnological innovation – utilizing the latest technologies while always providing holistic, outstanding healthcare. Sheba is strongly committed to delivering personalized, expert medicine to patients from all over the world.


The 10 Best Hospitals in the World

Request a consultation